STAT3 and hepatocellular carcinoma: The transcription factor STAT3, which has been widely researched, is highly activated in HCC patients either directly by different cytokines and growth factors, or indirectly by the activation of the Ras/Raf/MEK/ERK pathway [5], [7], [10].